Full treatment of the costs and benefits is needed

BMJ 1996; 313 doi: 10.1136/bmj.313.7065.1143 (Published 2 November 1996)
Cite this as: BMJ 1996;313:1143.1

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. A S Wierzbicki,
  2. T M Reynolds
  1. Senior lecturer in chemical pathology St Thomas's Hospital, London SE1 7EH
  2. Consultant chemical pathologist Burton Hospitals, Burton on Trent, Staffordshire DE13 0RB

    EDITOR,—P D P Pharoah and W Hollingworth have produced an interesting article that is of little benefit to the debate on the health economics of lowering lipid concentrations.1 The life table approach suffers from the same deficiency as we2 have pointed out for the Sheffield risk factor table.3 Megnien et al have shown that the risk table does not differ significantly from the currently accepted guidelines …

    Access to the full text of this article requires a subscription or payment

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    THIS WEEK'S POLL